The average patient dropout rate for clinical trials is 30%, costing pharma companies tens of billions of dollars annually. A single day of delay in bringing a niche drug to market costs approximately $600,000–and up to $8 million per day for a blockbuster drug. 20% of trials are delayed 6 months or longer, while 80% fail completely to finish on time and as planned.